We recently published a list of the 12 Stocks to Buy That May Be Splitting Soon. In this article, we are going to take a look ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

In this article, we are going to take a look at where Eli Lilly and ... uptake of its Mounjaro and Zepbound drugs. Its ...

Eli Lilly plans to launch its blockbuster diabetes and weight-loss drug in major emerging markets like India, Brazil and ...

Eli Lilly (NYSE:LLY) saw a notable 10% increase in its stock price over the last month, driven by several important events.

Eli Lilly's stock is undervalued; defensive healthcare stocks shine amid uncertainty, and Eli Lilly drives growth. Click here ...

Shares of Eli Lilly and Company (NYSE:LLY – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the ...

A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight ...

Lilly makes tirzepatide, commercialized under the name Zepbound for weight loss and Mounjaro ... or is Lilly stock still a buy? Let's find out. So, first let's talk about the Eli Lilly story ...

or is Lilly stock still a buy? Let's find out. Image source: Getty Images. What's behind Lilly's double-digit revenue growth So, first let's talk about the Eli Lilly story so far. It's important ...